Table 2.
Villus damage | Crypt damage | Cellular infiltration | Goblet cell depletion | |
---|---|---|---|---|
Control (I) | 0 | 0 | 0.25±0.46 | 0 |
MTX (II) | 2.38±0.52 | 2.13±0.64 | 2.50±0.53 | 2.63±0.52 |
CVR (III) | 1.5±0.53 | 1.38±0.52 | 1.5±0.53 | 1.75±0.71 |
PMG (IV) | 2.0±0.53 | 1.63±0.74 | 2.13±0.64 | 2.13±0.64 |
p value | ||||
I-II | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
I-III | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
I-IV | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
II-III | 0.02 | 0.05 | 0.01 | 0.02 |
II-IV | 0.03 | 0.02 | 0.03 | 0.01 |
III-IV | 0.161 | 0.574 | 0.105 | 0.328 |
CVR; carvacrol, PMG; pomegranate, MTX; methotrexate.